GJENSIDIGE FORSIKRNG NK 2/ NO0010582521 /
2024-05-30 10:59:20 AM | Chg. - | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
16.01EUR | - | 4 Turnover: 64.04 |
16.21Bid Size: 200 | 16.33Ask Size: 190 | 8.07 bill.EUR | - | - |
GlobeNewswire
2:38 AM
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pe...
GlobeNewswire
2:00 AM
HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire
1:00 AM
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
12:43 AM
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
GlobeNewswire
06-02
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
06-02
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
06-02
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering